ATLASTransCode Therapeutics (RNAZ) earnings date: Nov 13, 2026
TransCode Therapeutics (RNAZ) reports earnings for the quarter ended Sep 30, 2026 on Fri, Nov 13, 2026.
Source: company filings and exchange data · Updated Nov 2, 2026
ATLAS view on RNAZ
| Last price | $1.62 (-0.6%) |
|---|---|
| Normal 1-day range (±1σ) | ±4.7% |
| Earnings beat history | Beat the EPS estimate in 2 of the last 8 reports |
These figures come from the same calibrated model and valuation as the TransCode Therapeutics stock page. They describe an ordinary period, not the earnings reaction itself, which is usually wider and can go either way.
TransCode Therapeutics reports on Nov 13, 2026. One email the day before, with ATLAS’s read on TransCode Therapeutics. You can switch it off at any time.
Alert me before RNAZ reportsFree to start. Creating an account takes under a minute.
Notify me when TransCode Therapeutics reports
Track RNAZ free Add TransCode Therapeutics to a free ATLAS watchlist and see its next report date in one place.
RNAZ earnings at a glance
| Next report (confirmed) | Fri, Nov 13, 2026 |
|---|---|
| Time | Not stated |
| Period | Quarter ended Sep 30, 2026 |
| Last report | Aug 14, 2026 · Miss |
| Beat rate (last 8 reports) | 2 of 8 (25%) |
| Average EPS surprise | -234.8% |
| Average move around a report | ±6.8% (last 8) |
| Sector | Healthcare · Biotechnology |
TransCode Therapeutics earnings history: last 8 reports
| Report date | EPS est. | EPS actual | Surprise | Result | Move* |
|---|---|---|---|---|---|
| Aug 14, 2026 | – | -$7.17 | – | Miss | -9.2% |
| May 29, 2026 | – | -$21.28 | – | Miss | +2.7% |
| Feb 25, 2026 | – | -$16.42 | – | Miss | +2.7% |
| Jan 17, 2026 | $0.38 | $0.34 | -10.5% | Miss | +4.9% |
| Dec 17, 2025 | -$0.36 | $0.10 | +127.8% | Beat | -13.8% |
| Apr 15, 2025 | -$89.88 | -$1,286.15 | -1,331.0% | Miss | -12.9% |
| Nov 14, 2024 | -$452.76 | -$147.84 | +67.4% | Beat | -6.6% |
| Aug 14, 2024 | -$21,436.81 | -$27,350.42 | -27.6% | Miss | +1.2% |
*Move: change in the closing price from the last close before the report day to the close the day after it, so it captures the reaction whether the company reported before the open or after the close.
Get the full ATLAS analysis for RNAZ
See the fair value, the probability range and the earnings history of TransCode Therapeutics on its ATLAS page.
TransCode Therapeutics (RNAZ) stock analysisPlans from €3.99 a month.
TransCode Therapeutics earnings: frequently asked questions
When does TransCode Therapeutics (RNAZ) report earnings?
TransCode Therapeutics is scheduled to report on Friday, November 13, 2026 (the time of day has not been stated). ATLAS only shows a confirmed date when the company or the exchange data provides one; check the investor relations page for the call details.
How often does RNAZ beat earnings estimates?
Of its last 8 reports with a recorded result, TransCode Therapeutics beat the EPS estimate 2 times; the average surprise was -234.8%. Past results do not predict the next one.
How much does RNAZ move around earnings?
Over its last 8 reports the stock moved an average of 6.8% (absolute, from the close before the report day to the close after it), and finished higher 4 of 8 times.
How much does RNAZ usually move in a day?
On a normal trading day the ATLAS model puts RNAZ’s one-day range at about ±4.7%, with a 49% chance of closing higher. This is not an options-implied earnings move; earnings days are usually wider.
Also reporting on Fri, Nov 13, 2026
Educational information, not investment advice. Disclaimer